Expand BTAI Menu
BTAI MENU

BTAI Latest Press Releases

-- April 1, 2026 --

BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI in the At-Home Setting Globe Newswire 7:00 AM

-- March 27, 2026 --

BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI Approval in Outpatient Setting Globe Newswire 7:00 AM

-- March 23, 2026 --

Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of BioXcel Therapeutics, Inc. Globe Newswire 8:00 AM

-- March 11, 2026 --

BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering Globe Newswire 4:20 PM

-- March 10, 2026 --

BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering Globe Newswire 2:36 PM

-- March 5, 2026 --

BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal Globe Newswire 7:00 AM

-- February 19, 2026 --

BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer's Dementia Globe Newswire 7:00 AM

-- February 12, 2026 --

BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI in the At-Home Setting Globe Newswire 7:00 AM

-- January 20, 2026 --

BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI Label Expansion in the At-Home Setting Globe Newswire 7:00 AM

-- January 15, 2026 --

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire 12:44 PM

-- January 12, 2026 --

BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI in the At-Home Setting Globe Newswire 7:00 AM

-- January 7, 2026 --

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI Globe Newswire 7:00 AM

-- December 3, 2025 --

Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions Globe Newswire 7:00 AM

-- November 12, 2025 --

BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer's Disease Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes